A groundbreaking trial for TYRA-300, an oral FGFR3 inhibitor, aims to transform treatment for patients with low-grade ...

Sam S. Chang MD, MBA, discusses intravesical mitomycin in low-grade intermediate-risk nonmuscle-invasive bladder cancer vs ...

A mucoadhesive nanoplatform improves bladder cancer imaging by selectively targeting tumors and enhancing visualization for more precise non-invasive diagnosis.

The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).

TURBT was associated with persistent sexual dysfunction in men, pointing to the importance of incorporating sexual health into postoperative evaluation.

TYRA-300 is the only orally administered investigational agent in clinical development for IR NMIBC- -Initial 3-month complete response (CR) data expected to be reported ...

A breakthrough in bladder cancer treatment at the University of California, Davis: multifunctional nanoparticles enhance ...

The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing an alternative treatment as opposed to traditional surgical procedures. U.S ...

The FDA approved mitomycin intravesical solution (Zusduri) as a nonsurgical option for recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC). The product won the indication ...

Interdisciplinary Genitourinary Cancer Forum featured a management of non muscle invasive bladder cancer session and a presentation by Dr. Bernard Bochner discussing clinical trial design in this ...

Patients were stratified into two cohorts: cohort A consisted of 15 patients with residual tumor or CIS following transurethral resection of bladder tumor (TURBT) and cohort B comprised five patients ...

TURBT Transurethral resection of bladder tumor (TURBT, also known as transurethral resection, or TUR) is the most common surgery for bladder cancer that’s in early stages. Doctors take samples ...